- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03108170
Digital Perineal Massage and Pelvic Floor Muscle Exercise During Pregnancy for Prevention of Perineal Laceration
July 13, 2020 updated by: Eman Omran, Cairo University
Digital Perineal Massage and Pelvic Floor Muscle Exercise as an Antenatal Program for Prevention of Perineal Trauma in Elderly Women, a Randomized Controlled Trial
Pregnant participants will be recruited at the obstetrics outpatient clinic during their visits 4 weeks before the due date.
They are randomized into two groups.
The first group will be educated to do digital perineal massage.
They will be also educated to do pelvic floor muscle exercises and will receive the usual education program for strengthening the pelvic floor.
The second group will receive the usual education program for strengthening the pelvic floor.
Occurrence of perineal laceration will be reported at time of delivery.
Study Overview
Status
Completed
Conditions
Detailed Description
Pregnant participants will be recruited at the obstetrics outpatient clinic during their visits 4 weeks before the due date.
They are randomized into two groups.
The first group will be educated to do digital perineal massage.
They will be also educated to do pelvic floor muscle exercises and will receive the usual educational pelvic floor dysfunction prevention program for strengthening the pelvic floor.
The second group will receive the usual education program for strengthening the pelvic floor.
Occurrence of perineal laceration will be reported at time of delivery.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Greater Cairo
-
Cairo, Greater Cairo, Egypt, 11956
- Department of Obstetrics and Gynecology, Kasr Al-Ainy hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women ≥ 35 years old
- Primigravida or multi gravida
Exclusion Criteria:
- History of chronic constipation
- History of chronic cough
- Current or past urinary or anal incontinence
- History of genital prolapse before pregnancy
- History of neuromuscular disorders or connective tissue disorders
- History of medical disorders
- History of preterm or precipitate labour
- History of premature preterm rupture of membranes.
- Genital infections
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 3 programs group
The participants will receive 3 programs.The educational pelvic floor dysfunction prevention program, pelvic floor muscle exercise program and perineal massage program will be educated by an investigator during the participant visit 4 weeks before her duo date
|
The participant will perform digital massage of her perineal area 5 minutes daily starting four weeks before delivery till her actual labour day
The participant will perform pelvic floor muscle exercise daily starting four weeks before delivery till her actual labour day
This educational pelvic floor dysfunction prevention program includes instructions about: control of her weight, adequate cleaning for the perineal area, adequate fluid intake, smoking cessation, right posture and frequency of micturition and adequate ingestion of fiber to avoid constipation
|
|
Active Comparator: one program group
The participants will receive one program.
That is the educational pelvic floor dysfunction prevention program.The instructions of the program will be given by an investigator once during the participant visit 4 weeks before her duo date.
|
This educational pelvic floor dysfunction prevention program includes instructions about: control of her weight, adequate cleaning for the perineal area, adequate fluid intake, smoking cessation, right posture and frequency of micturition and adequate ingestion of fiber to avoid constipation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of participants who have perineal tears
Time Frame: At 15 minutes from delivery
|
Proportion of perineal tears will be assessed by an investigator who will attend the participant delivery
|
At 15 minutes from delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of participants who need episiotomy at time of delivery
Time Frame: At 15 minutes from delivery
|
Proportion of participants who need episiotomy at time of delivery will be assessed by an investigator
|
At 15 minutes from delivery
|
|
Duration of the second stage of labour
Time Frame: At 15 minutes from delivery
|
Duration of the second stage of labour will be assessed by an investigator
|
At 15 minutes from delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eman Omran, M.D., Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 12, 2017
Primary Completion (Actual)
December 20, 2018
Study Completion (Actual)
December 25, 2018
Study Registration Dates
First Submitted
April 5, 2017
First Submitted That Met QC Criteria
April 10, 2017
First Posted (Actual)
April 11, 2017
Study Record Updates
Last Update Posted (Actual)
July 15, 2020
Last Update Submitted That Met QC Criteria
July 13, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 3644
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.